Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Bioxytran Inc (BIXT)

Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline ACN Newswire - Thu Jan 29, 5:57AM CST

Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline

BIXT : 0.0426 (-9.36%)
Bioxytran Announces Initiation of Coverage of its Stock by Independent Research GlobeNewswire - Thu Nov 13, 2025

BOSTON, MASSACHUSETTS, Nov. 13, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical-stage biotech company focused on innovative treatments for stroke, Alzheimer’s,...

BIXT : 0.0426 (-9.36%)
Bioxytran Completes Randomized Clinical Trial For its Broad-Spectrum Antiviral Drug GlobeNewswire - Wed Oct 29, 2025

Data from the dose optimization trial expected soon ProLectin-M is positioned as the first oral antiviral sugar chemistry drug BOSTON, MASSACHUSETTS, Oct. 29, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN,...

BIXT : 0.0426 (-9.36%)
Bioxytran Unveils Revolutionary Precision Diagnostics on Tissue Oxygenation GlobeNewswire - Fri Aug 15, 2025

Game changer for stroke, Alzheimer’s, and beyond  Shifting from peripheral to tissue-specific oxygenation monitoring BOSTON, MASSACHUSETTS, Aug. 15, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC....

BIXT : 0.0426 (-9.36%)
Bioxytran’s Breakthrough Broad-Spectrum Antiviral Technology Poised to Revolutionize Respiratory Infection Treatment GlobeNewswire - Thu Aug 7, 2025

- ProLectin-M is currently being developed under an active Investigational New Drug (IND) application with the FDA BOSTON, MASSACHUSETTS, Aug. 07, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB:...

BIXT : 0.0426 (-9.36%)
Bioxytran Secures a Source of GMP Quality Camel Hemoglobin GlobeNewswire - Wed Jun 18, 2025

BIXT : 0.0426 (-9.36%)
Bioxytran’s Groundbreaking Stroke & Alzheimer’s Tech Gains Validation That Measures Oxygenation Uptake During Strokes GlobeNewswire - Tue Jun 3, 2025

BIXT : 0.0426 (-9.36%)
Bioxytran’s Antiviral Breakthrough Featured in University of Georgia’s $100M HPAI Poultry Innovation Grand Challenge Submission GlobeNewswire - Wed May 21, 2025

BIXT : 0.0426 (-9.36%)
Bioxytran Completes Dose Optimization of Antiviral, ProLectin-M GlobeNewswire - Mon May 12, 2025

BIXT : 0.0426 (-9.36%)
Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements GlobeNewswire - Fri Apr 11, 2025

BIXT : 0.0426 (-9.36%)

Barchart Exclusives

These 3 Dividend Stocks Could Soar in 2026 Barchart - Fri Jan 30, 6:00PM CST
After a volatile start to 2026, these three dividend stocks combine strong early momentum, analyst support, and income potential for the year ahead. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot